Geriatric Assessments in Senior Adults With Multiple Myeloma
NCT01746030 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42
Last updated 2015-11-20
Summary
This study will evaluate the prevalence of geriatric syndromes in older adults with multiple myeloma, examine relationships between baseline geriatrics syndromes and initial treatment selection, and examine risk of functional decline.
Relationship between baseline geriatric questionnaires and initial treatment selection in older adults with newly diagnosed multiple myeloma.
Feasibility of subjects completing the CARG geriatric assessments at baseline, 3 months and 6 months.
Comorbidities or dependence in IADLs at baseline predict decline in functional status at 6 months of follow-up in older adults with newly diagnosed multiple myeloma.
Conditions
Sponsors & Collaborators
-
Washington University School of Medicine
lead OTHER
Principal Investigators
-
Tanya Wildes, M.D. · Washington University School of Medicine
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-09-30
- Primary Completion
- 2014-12-31
- Completion
- 2015-07-31
Countries
- United States
Study Locations
More Related Trials
-
Comparison of Geriatric Screening Methods in Newly Diagnosed Multiple Myeloma Patients
NCT02918695 ·Status: COMPLETED
-
Cohort Construction and Prognostic Model Construction for Multiple Myeloma
NCT06366802 ·Status: ACTIVE_NOT_RECRUITING
-
Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial
NCT06212323 ·Status: RECRUITING
-
A Multicenter Cross-sectional Study on Mental Health of Patients With Multiple Myeloma
NCT05620420 ·Status: COMPLETED
-
A Comparative Clinical Study to Determine the Optimal Initial Therapy for Multiple Myeloma
NCT06151717 ·Status: COMPLETED
-
S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
NCT00900263 ·Status: COMPLETED
-
Oligosecretary Myeloma: Prevalence and Its Clinical Significance
NCT02095379 ·Status: COMPLETED
-
Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma
NCT00002653 ·Status: UNKNOWN ·Phase: PHASE3
-
Precision Medicine Study
NCT06338150 ·Status: RECRUITING
-
A Study Evaluating Hypotension and Autonomic Nervous System Dysfunction in Multiple Myeloma (MM) Patients
NCT01314625 ·Status: UNKNOWN
-
Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
NCT03127761 ·Status: RECRUITING
-
Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
NCT05136807 ·Status: RECRUITING
-
Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma
NCT00036140 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of a Resistance Physical Exercise Program in Multiple Myeloma Patients
NCT07253103 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Biomarkers in Multiple Myeloma
NCT05259553 ·Status: RECRUITING ·Phase: NA
-
Exercise Prescription for the Improvement of Quality of Life in Elderly Patients With Multiple Myeloma
NCT04100044 ·Status: COMPLETED ·Phase: NA
-
Assessment of Mobilization Cost for Multiple Myeloma Using 2 Different Mobilization Strategies
NCT02997813 ·Status: COMPLETED
-
A Study to Investigate the Relationship Between Duration of Treatment and Response in Patients With Multiple Myeloma (MM) or Systemic AL Amyloidosis Treated in Real-life Practice
NCT04659798 ·Status: COMPLETED
-
S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.
NCT00919139 ·Status: COMPLETED
-
Neurocognitive and Neuroimaging Outcomes in Older Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplantation
NCT03508765 ·Status: COMPLETED ·Phase: NA
-
Lenalidomide Adherence in Older Adults
NCT03779555 ·Status: TERMINATED
-
Autologous Stem Cell Transplantation for Myeloma Patients Over 65 Years
NCT01671826 ·Status: UNKNOWN
-
A Clinical Trial Evaluating the Safety Tolerability, Radiation Absorption Dose, Distribution, PET Imaging and Histological Expression of 68Ga-NOTA-SCH001 in Patients With Multiple Myeloma
NCT06925958 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Impacts on Health Outcomes and Resources Utilization of Hospital-at-home for Elderly Patients With Multiple Myeloma
NCT03490084 ·Status: UNKNOWN
-
MRI in Multiple Myeloma: Analysis of the Axial Skeleton Versus Whole Body. What is the Required Analysis?
NCT03618212 ·Status: TERMINATED